SCHEMBL6607566

SCHEMBL6607566

CC1=C(C#N)C(c2ccc(F)c(-c3cccnc3)c2)NC(=O)N1C(=O)O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B2 P19099 4/20 0.39
CYP11B1 P15538 2/20 0.37
ELANE P08246 2/20 0.36
CYP2C9 P11712 1/20 0.36
PARP1 P09874 1/20 0.36
ALDH1A1 P00352 5/20 0.36
KDM4E B2RXH2 4/20 0.36
GLA P06280 4/20 0.36
GAA P10253 4/20 0.36
HPGD P15428 4/20 0.36
HTT P42858 2/20 0.36
NPSR1 Q6W5P4 1/20 0.36
AKR1C3 P42330 1/20 0.36
AKR1C2 P52895 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
CASP1 P29466 1/20 0.35
CASP7 P55210 1/20 0.35
HSD17B10 Q99714 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
XDH P47989 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6608080 0.87 ALDH1A1 (0.40) CYP11B2CYP11B1ELANECYP2C9ALDH1A1
SCHEMBL6607779 0.85 MEN1 (0.37) CYP11B2CYP11B1ELANEALDH1A1SMN1; SMN2
SCHEMBL6609381 0.84 CACNA1C (0.41) CYP11B2CYP11B1ELANECYP2C9ALDH1A1
SCHEMBL6312851 0.81 ALDH1A1 (0.46) CYP11B2CYP11B1PARP1ALDH1A1KDM4E
SCHEMBL6606626 0.80 CYP11B2 (0.38) CYP11B2CYP11B1ELANECYP2C9ALDH1A1
SCHEMBL6311789 0.79 ALDH1A1 (0.42) CYP11B2CYP11B1ELANECYP2C9ALDH1A1
SCHEMBL6137082 0.77 TDP1 (0.50) ELANECYP2C9ALDH1A1
SCHEMBL6137118 0.75 HTT (0.43) ELANECYP2C9ALDH1A1HPGDHTT
SCHEMBL6609236 0.73 ELANE (0.45) ELANECYP2C9NPSR1CASP1CACNA1C
SCHEMBL6137365 0.73 ELANE (0.40) ELANECYP2C9ALDH1A1KDM4EGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1373223-A4 CYANO-SUBSTITUTED DIHYDROPYRIMIDINE COMPOUNDS AND THEIR USE TO TREAT DISEASES BRISTOL MYERS SQUIBB CO (US) 2004-09-29 EP claimed
EP-1373223-A1 CYANO-SUBSTITUTED DIHYDROPYRIMIDINE COMPOUNDS AND THEIR USE TO TREAT DISEASES Bristol-Myers Squibb Company (US) 2004-01-02 EP claimed
WO-2002079169-A1 CYANO-SUBSTITUTED DIHYDROPYRIMIDINE COMPOUNDS AND THEIR USE TO TREAT DISEASES BRISTOL-MYERS SQUIBB COMPANY (US) 2002-10-10 WO claimed
EP-1373223-A4 CYANO-SUBSTITUTED DIHYDROPYRIMIDINE COMPOUNDS AND THEIR USE TO TREAT DISEASES BRISTOL MYERS SQUIBB CO (US) 2004-09-29 EP disclosed
EP-1373223-A1 CYANO-SUBSTITUTED DIHYDROPYRIMIDINE COMPOUNDS AND THEIR USE TO TREAT DISEASES Bristol-Myers Squibb Company (US) 2004-01-02 EP disclosed
WO-2002079169-A1 CYANO-SUBSTITUTED DIHYDROPYRIMIDINE COMPOUNDS AND THEIR USE TO TREAT DISEASES BRISTOL-MYERS SQUIBB COMPANY (US) 2002-10-10 WO disclosed